Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
the organisation of seminars, conferences and activities. About you PhD in liver physiology, cell biology or diabetes A background in pharmacology or pharmacy experience in working on liver based experiments using
-
The scholarship will fund a 3 year PhD candidature to work in the Chemistry Department of the School of Science CAMIC Laboratory. The project is a collaboration with Assoc. Prof Ravi Shukla to test
-
For the second year running, Monash University has been ranked number two in the world for Pharmacy and Pharmacology in the 2024 Quacquarelli Symonds (QS) World University Rankings by Subject! The Faculty
-
For the second year running, Monash University has been ranked number two in the world for Pharmacy and Pharmacology in the 2024 Quacquarelli Symonds (QS) World University Rankings by Subject! The Faculty
-
candidates, staff and industry, together with a strong commitment to teamwork and multidisciplinary collaboration. Mandatory: PhD in a relevant field, and current registration with the Australian Health
-
or lead research dissemination as appropriate to the role. About you Level A Postdoctoral Research Associate (Research Only) hold a research Masters or a PhD in a relevant discipline have at least 2 years
-
Immunology, Pathology and Laboratory Science, and Pharmacology and Toxicology. The School is very active in teaching undergraduate Biomedical Science and Medical students across a wide range of majors and
-
pharmacology of social behaviour. The successful applicant will be supervised by and work closely with Dr Nick Everett, within a larger translational program led by Professor Michael Bowen which currently has
-
skills that support effective research collaboration and engagement. You will pay high attention to detail and can appropriately operate sensitive and precise scientific equipment. You will also have: PhD
-
. The candidate will be enrolled in the PhD program at the Department of Pharmacology & Toxicology at the University of Toronto, and in the PhD program at the Sir Peter MacCallum Department of Oncology